Open AccessFeasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer
Author(s) -
Arti Parekh,
Paul L. Nguyen,
Laura West,
Catherine Duarte,
Powell L. Graham,
Dennis R. LaRock,
Vincent Yeung,
Mark Hurwitz
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.180083
Subject(s) - medicine , brachytherapy , hazard ratio , prostate cancer , confidence interval , proportional hazards model , prostate specific antigen , urology , prostate , clinical endpoint , cohort , cancer , radiation therapy , oncology , randomized controlled trial
We sought to determine whether patients with high-volume, low-risk prostate cancer are suitable candidates for ultrasound-guided brachytherapy, monotherapy alone, without supplemental external beam radiation.